Old unsolved problems: when and how to treat silent ischaemia.

Area of Science:

• Cardiology
• Ischaemic Heart Disease

Background:

• Silent myocardial ischaemia (SMI) is defined by objective evidence of myocardial ischaemia without angina in patients with coronary artery disease.
• SMI constitutes the majority of ischaemic episodes detected during Holter monitoring.
• The precise mechanisms underlying SMI remain incompletely understood.

Purpose of the Study:

• To explore the underlying causes and potential mechanisms of silent myocardial ischaemia.
• To review the historical and current understanding of SMI's prognosis and its association with conditions like diabetes mellitus.

Main Methods:

• Review of existing literature and clinical observations regarding silent myocardial ischaemia.
• Analysis of factors potentially contributing to SMI, including ischaemia severity, duration, pain perception thresholds, and neuronal dysfunction.

Main Results:

• SMI is more prevalent than symptomatic ischaemia.
• Potential mechanisms include ischaemia characteristics, altered pain perception, and neuronal dysfunction (e.g., in diabetes or post-infarction).
• Historically, SMI was linked to poorer outcomes, particularly in diabetic patients with autonomic dysfunction.

Conclusions:

• Silent myocardial ischaemia is a frequent phenomenon, often exceeding symptomatic presentations.
• The prognosis of SMI and the impact of medical therapy require further clarification.
• Further research is needed to elucidate the exact role of various proposed mechanisms and to establish definitive prognostic guidelines.